| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |